About

Click our LIKE button and Share-With-A-Friend the good news and the hope many now have for a cure to mesothelioma lung cancer with Dr. Parkash Gill’s research progress!

NEWS RELEASE

September 2012

Dr. Parkash Gill announced at the John’s fund raising event in San Diego that his addictive protein EPH-B4 is attracted only to specific cancer cells and is manufactured in San Diego.

Please use our FaceBook link  to obtain your FREE copy of our eBook that teaches you 10 easy steps on how to find and choose a clinical trial for Mesothelioma and how to prepare for it!

Ask Dr. Gill about the most recent clinical trials avaialble

 

 

Ask Dr. Gill about your specific mesothelioma issues here: Ask Dr. Gill

 

Learn more about Clinical Trials at this cancer research link: read more…

 

 

In addition to the eBook found at our Facebook fan page, also learn more about clinical trials from these links:

Mesothelioma Research Foundation of America brings Veglin mesothelioma treatment

The Mesothelioma Research Foundation of America has a mission: fund research that will lead to the quickest cure for mesothelioma.  Mesothelioma is a cancer of the lining of the lungs caused by asbestos exposure.  This cancer disease had few treatment options until this Foundation and Dr. Parkash Gill’s work created better treatment options.  Today, the future looks more hopeful for additional improved treatment options available to those stricken by this cancer.

The Mesothelioma Research Foundation of America began funding research for a cure in 2001 with the opening of the Mesothelioma Laboratory at USC Norris Comprehensive Cancer Medical Center in Los Angeles under the supervision of Dr. Parkash Gill.

Dr. Gill's research with mesothelioma drugs under FDA approved clinical trials
Clinical trials of Dr. Parkash Gill’s drugs

Dr. Gill is a board certified oncologist and hematologist who has received FDA approval from the U.S. Government to do Clinical Trials on a mesothelioma treatment drug called Veglin. We believe there is great promise and hope in Veglin and the Mesothelioma Research Foundation of America has funded 100% of Dr. Gill’s research.

Veglin proved successful in Phase I and Phase II clinical trials. Many are very hopeful for the possibilities of a more effective cancer treatment compared to what presently is available for mesothelioma victims.